Known targets — ChEMBL curated mechanism
ACHEBDKRB2CHRM1CHRM2CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNGGUCY1A1GUCY1A2GUCY1B1GUCY1B2NAMPTPTAFRSLC10A2SLC6A2SLC6A3TACR1dacAdacBdacCftsImrcAmrcBmrdA
The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRM2 known ✓ | P08172 | 2/20 | 0.61 |
| ▸ | CHRM1 known ✓ | P11229 | 2/20 | 0.61 |
| ▸ | ACHE known ✓ | P22303 | 2/20 | 0.61 |
| ▸ | SLC6A2 known ✓ | P23975 | 2/20 | 0.61 |
| ▸ | SLC6A3 known ✓ | Q01959 | 2/20 | 0.61 |
| ▸ | CHRM3 known ✓ | P20309 | 1/20 | 0.59 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.95 |
| ▸ | MEN1 | O00255 | 3/20 | 0.95 |
| ▸ | MAPT | P10636 | 2/20 | 0.95 |
| ▸ | TP53 | P04637 | 1/20 | 0.95 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.95 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.95 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.95 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.95 |
| ▸ | HTT | P42858 | 4/20 | 0.91 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.91 |
| ▸ | LMNA | P02545 | 2/20 | 0.91 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.91 |
| ▸ | NPC1 | O15118 | 1/20 | 0.91 |
| ▸ | RAB9A | P51151 | 1/20 | 0.91 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL4089294 | 1.00 | KMT2A (0.95) | KMT2AMEN1MAPTTP53CYP1A2 | |
| Hydrochloric Acid SCHEMBL4078161 | 1.00 | KMT2A (0.95) | KMT2AMEN1MAPTTP53CYP1A2 | |
| Hydrochloric Acid SCHEMBL25220224 | 1.00 | KMT2A (0.95) | KMT2AMEN1MAPTTP53CYP1A2 | |
| Hydrochloric Acid SCHEMBL1449133 | 1.00 | KMT2A (0.95) | KMT2AMEN1MAPTTP53CYP1A2 | |
| SCHEMBL1108039 | 0.98 | KMT2A (1.00) | KMT2AMEN1MAPTTP53CYP1A2 | |
| SCHEMBL3196438 | 0.98 | KMT2A (1.00) | KMT2AMEN1MAPTTP53CYP1A2 | |
| SCHEMBL3221223 | 0.98 | KMT2A (1.00) | KMT2AMEN1MAPTTP53CYP1A2 | |
| SCHEMBL3212749 | 0.98 | KMT2A (1.00) | KMT2AMEN1MAPTTP53CYP1A2 | |
| SCHEMBL3215320 | 0.98 | KMT2A (1.00) | KMT2AMEN1MAPTTP53CYP1A2 | |
| Hydrochloric Acid SCHEMBL25217017 | 0.98 | KMT2A (0.91) | KMT2AMEN1MAPTTP53CYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20060033088-A1 | Polymer for a photochromic compound matrix, and a matrix comprising the said polymer | GYONGTAE KIM (KR) | 2006-02-16 | — | — | US | claimed |
| EP-1598408-A1 | A polymer for a photochromic compound matrix, and a matrix comprising the said polymer | Kim, Gyongtae (KR) | 2005-11-23 | — | — | EP | claimed |
| US-12622871-B2 | DNA-based electrochromic hydrogel and electrochromic device comprising same | UNIVERSITY OF SEOUL INDUSTRY COOPERATION FOUNDATION (KR) | 2026-05-12 | — | — | US | disclosed |
| US-12624233-B2 | DNA based biodegradable resin composition | UNIVERSITY OF SEOUL INDUSTRY COOPERATION FOUNDATION (KR) | 2026-05-12 | — | — | US | disclosed |
| US-20240180824-A1 | DNA-based electrochromic hydrogel and electrochromic device comprising same | UNIVERSITY OF SEOUL INDUSTRY COOPERATION FOUNDATION (KR) | 2024-06-06 | — | — | US | disclosed |
| CN-117043234-A | Composition containing radical polymerization initiator | PRC-迪索托国际公司 | 2023-11-10 | — | — | CN | disclosed |
| US-20230167315-A1 | DNA based biodegradable resin composition | UNIVERSITY OF SEOUL INDUSTRY COOPERATION FOUNDATION (KR) | 2023-06-01 | — | — | US | disclosed |
| US-7404915-B2 | Electromagnetic wave shielding material, method of manufacturing the same and electromagnetic wave shielding material for plasma display panel | KONICA MINOLTA MEDICAL & GRAPHIC, INC. (JP) | 2008-07-29 | — | — | US | disclosed |
| US-20070138441-A1 | Electromagnetic wave shielding material, method of manufacturing the same and electromagnetic wave shielding material for plasma display panel | KONICA MINOLTA MEDICAL & GRAPHIC, INC. (JP) | 2007-06-21 | — | — | US | disclosed |
| US-20070015094-A1 | ELECTROMAGNETIC WAVE SHIELDING MATERIAL, METHOD FOR MANUFACTURING THE SAME AND ELECTROMAGNETIC WAVE SHIELDING MATERIAL FOR PLASMA DISPLAY PANEL | KONICA MINOLTA MEDICAL & GRAPHIC, INC. (JP) | 2007-01-18 | — | — | US | disclosed |
| US-20060033088-A1 | Polymer for a photochromic compound matrix, and a matrix comprising the said polymer | GYONGTAE KIM (KR) | 2006-02-16 | — | — | US | disclosed |
| EP-1598408-A1 | A polymer for a photochromic compound matrix, and a matrix comprising the said polymer | Kim, Gyongtae (KR) | 2005-11-23 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12622871-B2 | DNA-based electrochromic hydrogel and electrochromic device comprising same | ERCC1, ERCC2, ERCC5 | CHRM2 244/4885CHRM1 211/4885ACHE 1463/4885 |
| US-20240180824-A1 | DNA-based electrochromic hydrogel and electrochromic device comprising same | DNMT3A, DNMT1, DNA2 | CHRM2 970/4885CHRM1 1458/4885ACHE 848/4885 |
| US-12624233-B2 | DNA based biodegradable resin composition | PARP1, LIG1, PBRM1 | CHRM2 1954/4885CHRM1 2120/4885ACHE 4693/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.